Key takeaways
- B12 is a cofactor for exactly two enzymes, covering methylation, myelin, red cell production and mitochondrial metabolism.
- Neurological damage frequently precedes anaemia and recovers far less completely.
- Optimal is above 500 pg/mL; the reference floor of 200 was built to catch anaemia, not neuropathy.
- Methylmalonic acid is the functional marker that settles a borderline serum result.
B12 deficiency is one of the few genuinely common nutrient problems that can cause permanent damage while every routine test still reads normal. The reason is structural: the standard blood test measures a number that correlates loosely with whether the vitamin is actually working, and the reference range beneath it was drawn to catch anaemia rather than the neurological injury that usually arrives first. People spend years being told their B12 is fine while the part that matters most is quietly failing.
The two jobs B12 has
Almost everything about this topic makes more sense once you know that B12 is a cofactor for exactly two enzymes in the human body, and that they do unrelated things.
Methionine synthase converts homocysteine back into methionine, and methionine becomes SAM-e, the universal methyl donor. Methylation is how the body switches genes on and off, builds neurotransmitters, and maintains myelin — the insulating sheath around nerves. This reaction also requires folate, which is why B12 and folate are permanently entangled and why a problem with one shows up as a problem with the other.
Methylmalonyl-CoA mutase sits inside mitochondria and handles a step in the breakdown of certain fatty acids and amino acids. When B12 is short, its substrate backs up as methylmalonic acid — which is the entire basis of the best functional test available, discussed below.
Two enzymes, one vitamin, a very wide symptom footprint — DNA synthesis, red cell formation, myelin maintenance, energy metabolism and homocysteine clearance all run through one or the other. Homocysteine and methylation covers the downstream marker.
What deficiency looks like — and why the order matters
- Numbness and tingling from peripheral neuropathy, which frequently appears before any anaemia does (Lindenbaum et al., N Engl J Med 1988)
- Brain fog and memory difficulty
- Fatigue that does not respond to sleep
- Mood change, including depression and irritability
- Macrocytic anaemia — enlarged red blood cells
- Glossitis, a sore and smooth tongue
- Balance problems and unsteadiness, particularly in the dark
The sequencing is routinely got backwards. The traditional teaching is that deficiency causes anaemia and neurological problems arrive later in severe cases; in reality a substantial proportion of people with neuropsychiatric consequences have entirely normal blood counts. Waiting for anaemia before taking B12 seriously means waiting past the point where damage is happening.
It matters because the two kinds of damage recover differently. Anaemia corrects reliably and fairly quickly once B12 is replaced. Nerve damage recovers slowly, incompletely, and — if it has gone on long enough — sometimes not at all. That asymmetry is the whole argument for testing early and treating borderline results rather than watching them.
Why the serum number lies
- Reference range: roughly 200-900 pg/mL, and highly variable between laboratories
- Suboptimal: 200-400
- Optimal: above 500
- The "normal" lower limit of 200 misses a great many functional deficiencies
Three problems make serum B12 a poor standalone test. It measures total circulating B12, most of it bound to a protein that cannot deliver it into cells, so the number includes a large inert fraction. The reference range was validated against haematological deficiency — built to catch anaemia rather than neuropathy. And several conditions raise serum B12 independently of status, so a normal result does not exclude functional deficiency.
This is a specific instance of a general problem with reference ranges against optimal ranges: a range built from a population tells you what is common, not what is sufficient. Anyone in the 200-400 band with neurological or cognitive symptoms should be treated as potentially deficient until a functional marker says otherwise.
The test that settles it
Methylmalonic acid is the marker that answers the question serum B12 cannot. Because B12 is required to clear methylmalonyl-CoA, methylmalonic acid rises when B12 is functionally inadequate inside cells — regardless of what is floating in the blood (Savage et al., Am J Med 1994). It is the difference between measuring how much fuel is in the tank and measuring whether the engine is running.
Homocysteine is the useful companion. It rises with B12 deficiency and with folate deficiency both, so it is sensitive but not specific. Read together, the pattern separates them: methylmalonic acid raised with homocysteine raised points at B12; homocysteine raised alone points at folate. That distinction changes what you supplement, which is why running both is worth the extra line on the order.
Methylcobalamin against the alternatives
- Methylcobalamin — the active methylated form; used directly in the methionine synthase reaction; preferred by many practitioners
- Cyanocobalamin — cheap, extremely stable, and the form used in most of the evidence base; requires conversion in the body
- Hydroxocobalamin — the usual injectable form; longer-acting in tissue
- Adenosylcobalamin — the mitochondrial form, sometimes paired with methylcobalamin
The honest version of a claim that is usually overstated: the argument for methylcobalamin is that it skips a conversion step and therefore suits people with methylation enzyme variants such as MTHFR. That reasoning is plausible — but MTHFR variants principally affect folate processing rather than B12 conversion, and head-to-head evidence favouring methylcobalamin over cyanocobalamin in ordinary deficiency is thin. Form is a second-order question. Whether you are absorbing anything at all, and at an adequate dose, matters far more than which cobalamin is on the label. Methylcobalamin is a reasonable default with no real downside. It is not the reason someone gets better.
Why absorption fails
B12 absorption is unusually complicated, which is why it is unusually easy to break. It requires stomach acid to free the vitamin from dietary protein, intrinsic factor produced by gastric parietal cells to escort it, and a healthy terminal ileum where the pair is finally taken up. Three separate points of failure, any one of which is sufficient.
- Ageing, through declining stomach acid production
- Proton pump inhibitors, which suppress the acid the first step depends on (Lam et al., JAMA 2013)
- Metformin, which impairs absorption at the ileal step (de Jager et al., BMJ 2010)
- Pernicious anaemia, an autoimmune loss of intrinsic factor
- Crohn's disease and coeliac disease, which damage the absorptive surface
- Vegan and vegetarian diets, where the problem is supply rather than absorption
The two drug-related causes deserve emphasis: long-term metformin and long-term acid suppression are among the most prescribed interventions in adult medicine, and neither routinely comes with B12 monitoring attached. The route of replacement then follows from the cause — where absorption is intact and the problem is dietary, oral works; where intrinsic factor or the ileum is at fault, injectable is the reliable answer, and for pernicious anaemia the standard one.
What to expect after replacement
Energy and mood tend to shift within weeks. Blood counts normalise over roughly a couple of months as new red cells replace the old population. Neurological recovery is the slow one — months at best, often incomplete if the deficiency ran for years, and this is where realistic expectations prevent disappointment. Numbness that has been present for a long time may improve rather than resolve.
One safety point that belongs on any page about this: never correct folate alone in someone who might be B12 deficient. High-dose folate can normalise the blood count and resolve the anaemia while the neurological damage continues unchecked, removing the very signal that would have prompted investigation. Check B12 status before treating a macrocytic anaemia with folate, not after.
The clinical pearl: a serum B12 in the 200-400 range is frequently functionally deficient even though the laboratory calls it normal. Add methylmalonic acid to confirm, and check homocysteine alongside to separate B12 from folate. Treat borderline results in anyone with neurological or cognitive symptoms rather than waiting for anaemia to appear — the anaemia recovers, the nerve damage may not.
Bottom line
B12 is a cofactor for two enzymes, and between them they cover methylation, myelin maintenance, red cell production and mitochondrial energy metabolism — which is why deficiency produces such a scattered picture. Neurological consequences frequently precede anaemia and recover far less completely, so the case for testing early and treating borderline results is strong. Aim above 500 pg/mL rather than above the reference floor of 200, and use methylmalonic acid to establish whether the vitamin is actually working. Anyone on long-term metformin or acid suppression should be checked regardless of symptoms.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
